Overexpression of Vasostatin‐1 Protects Hypoxia/Reoxygenation Injuries in Cardiomyocytes Independent of Endothelial Cells
Authors:
Open Access
- 22 May 2011
- journal article
- research article
- Published by Wiley in Cardiovascular Therapeutics
- Vol. 30 (3) , 145-151
Abstract
SUMMARY: Introduction: Vasostatin‐1 (VS‐1) has been suggested in protecting hypoxia/reoxygenation (H/R) injuries in isolated hearts. However, the molecular mechanisms remained to be elucidated. Methods: Cardiomyocytes were treated with recombinant Ad‐VS‐1 adenoviral vector before H/R. Cell viability was studied using MTT methods and annexin V‐FITC flow cytometry. Intracellular oxidative stress was measured by superoxide dismutase (SOD) and malondialdehyde (MDA), and inflammatory reactions by enzyme‐linked immunosorbent assay (ELISA). Measurement of myocardial nitrous oxide synthase (NOS) was determined by serum nitric oxide (NO) concentrations using nitrite reductase and endothelial nitric oxide synthase (eNOS) by Western blotting. Inhibitors of the NOS system, including hemoglobin and KT5823, were applied to verify the results. Results: In comparison of the blank group, cardiac myocytes overexpressing VS‐1 showed significant decrease in apoptosis, intracellular oxidative stress, and inflammatory reactions (P < 0.05). In addition, serum NO concentrations and expression of eNOS were notably enhanced (P < 0.05). These protective effects of VS‐1 were suppressed in the presence of apoptosis‐inducing agents. Conclusions: Overexpression of VS‐1 in cardiomyocytes could limit the H/R injuries at molecular levels. The protective effects were independent of endothelial cell function, suggestive of a potential therapeutic target for patients with myocardial ischemia in the future.Keywords
This publication has 27 references indexed in Scilit:
- Cell Death in the Pathogenesis of Heart Disease: Mechanisms and SignificanceAnnual Review of Physiology, 2010
- Human recombinant chromogranin A-derived vasostatin-1 mimics preconditioning via an adenosine/nitric oxide signaling mechanismAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Endothelium-derived nitric oxide mediates the antiadrenergic effect of human vasostatin-1 in rat ventricular myocardiumAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- THE ROLE OF POLYMORPHISMS OF GLUTATHIONE S-TRANSFERASES GSTM1, M3, P1, T1 AND A1 IN SUSCEPTIBILITY TO ALCOHOLIC LIVER DISEASEAlcohol and Alcoholism, 2004
- Hypoxia/reoxygenation stimulates Ca2+-dependent ICAM-1 mRNA expression in human aortic endothelial cellsBiochemical and Biophysical Research Communications, 2004
- Chromogranin A protects vessels against tumor necrosis factor α‐induced vascular leakageThe FASEB Journal, 2004
- Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthaseCardiovascular Research, 2003
- G protein‐mediated inhibitory effect of a nitric oxide donor on the L‐type Ca2+ current in rat ventricular myocytesThe Journal of Physiology, 2001
- Tumor necrosis factor-α induces apoptosis via inducible nitric oxide synthase in neonatal mouse cardiomyocytesCardiovascular Research, 2000
- Endothelial and myocardial injury during ischemia and reperfusion: Pathogenesis and therapeutic implicationsJACC, 1989